Here’s what you should know:
1. Valeant has paid all mandatory amortizations through 2019.
2. Since the first quarter of fiscal year 2016, Valeant reduced its debt by more than $4.3 billion.
3. Valeant executives believe the company will pay approximately $5 billion in debt by February 2018.
4. Valeant sold Dendreon Pharmaceuticals to Sanpower Group on June 29. .
More articles on gastroenterology:
The 20 states with the best and worst colorectal cancer screening rates
Takeda CEO facing pressure amid dismal profits — 4 key notes
Allergan sues Sun Pharma for patent infringement — 3 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
